Glaukos (GKOS) Research & Development (2014 - 2026)

Glaukos (GKOS) has 13 years of Research & Development data on file, last reported at $44.1 million in Q1 2026.

• Research & Development for Q1 2026 came in at $44.1 million, up 36.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $162.4 million (up 17.64% YoY), and the FY2025 annual result was $150.6 million, up 10.4% from the prior year.
• Research & Development advanced to $44.1 million in Q1 2026 per GKOS's latest filing, from $43.7 million in the prior quarter.
• Over five years, Research & Development peaked at $44.1 million in Q1 2026 and troughed at $26.9 million in Q1 2022.
• A 5-year average of $34.9 million and a median of $34.7 million in 2024 frame the typical range for Research & Development.
• The sharpest annual moves came in 2024 and 2026: Research & Development retreated 12.64% in 2024, then soared 36.45% in 2026.
• A 5-year view of Research & Development shows it stood at $35.8 million in 2022, then climbed by 3.49% to $37.1 million in 2023, then slipped by 1.44% to $36.5 million in 2024, then rose by 19.5% to $43.7 million in 2025, then rose by 1.13% to $44.1 million in 2026.
• Business Quant data shows GKOS's Research & Development at $44.1 million in Q1 2026, $43.7 million in Q4 2025, and $38.1 million in Q3 2025.